Can a common steroid stop lung fluid from coming back?
NCT ID NCT07039019
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether the steroid prednisone can prevent recurrent pleural effusions (fluid buildup around the lungs) in people with non-specific pleuritis. Forty adults will be randomly assigned to take prednisone daily for 4 weeks or receive no steroid. The study lasts 6 months and tracks how many people have fluid recurrence and need further procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Prednisone (a corticosteroid)
- What this could lead to
- If it works, this could point toward a simple treatment to prevent fluid buildup in the lungs for people with non-specific pleuritis.
- What could go wrong
- This is a very early pilot study with only 40 people, so results may not be conclusive. Corticosteroids also have side effects like weight gain and increased infection risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLEURITIS, NON-SPECIFIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mount Sinai Hospital
RECRUITINGNew York, New York, 10029, United States
-
Mount Sinai Morningside
RECRUITINGNew York, New York, 10029, United States